|
Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 58-63
|
Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
DNA;
PACLITAXEL;
ADVANCED CANCER;
AREA UNDER THE CURVE;
ARTICLE;
BEAM THERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TOXICITY;
MALE;
MUCOSA INFLAMMATION;
NECK DISSECTION;
NEUROTOXICITY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIATION DOSE;
RADIOSENSITIZATION;
TREATMENT OUTCOME;
TUMOR BIOPSY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
CONFIDENCE INTERVALS;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
PACLITAXEL;
PROSPECTIVE STUDIES;
RADIOTHERAPY DOSAGE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0032900182
PISSN: 10534296
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (38)
|
References (24)
|